文献速递乳房整形与再造

氨甲环酸在乳腺外科中的应用:系统综述与Meta分析

Tranexamic Acid Use in Breast Surgery: A Systematic Review and Meta-Analysis.
PubMed 文献 · Plast Reconstr Surg · 2022-12-19

该系统综述与Meta分析共纳入5项研究、1139例接受乳腺手术的患者,评估围手术期全身性氨甲环酸(TXA)给药的效果。结果显示,与对照组相比,TXA显著降低血肿风险(7.3% vs 12.9%;OR 0.43;95%CI 0.23-0.81)和血清肿形成风险(11.5% vs 19.9%;OR 0.57;95%CI 0.35-0.92),术后引流量平均差为132 mL(95%CI 220-44 mL),两组均未发生血栓栓塞事件。

要点

  • 围手术期静脉给予TXA显著降低乳腺手术后血肿风险(OR 0.43;95%CI 0.23-0.81)。
  • TXA组血清肿形成风险显著低于对照组(OR 0.57;95%CI 0.35-0.92)。
  • 两组均无血栓栓塞事件发生,对照组手术部位感染率较高(3.1% vs 1.5%),但数据过少未行比较Meta分析。

核心结论

  • 本研究的证据提示,围手术期给予TXA显著降低乳腺手术后血肿和血清肿形成风险,且不增加血栓栓塞事件和术后感染风险。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、MEDLINE、Embase、CENTRAL和CINAHL数据库,纳入随机临床试验和观察性研究,共5项研究、1139例接受乳腺手术的患者。
  • 效应量采用随机效应模型合并,以加权比值比(OR)及95%置信区间(CI)表示。

主要发现

  • 与对照组相比,围手术期静脉给予TXA显著降低血肿风险(7.3% vs 12.9%;OR 0.43;95%CI 0.23-0.81)。
  • 与对照组相比,TXA显著降低血清肿形成风险(11.5% vs 19.9%;OR 0.57;95%CI 0.35-0.92)。
  • 在测量术后引流量的研究中,平均差为132 mL(95%CI 220-44 mL)。
  • 两组均无血栓栓塞事件发生。
  • 对照组加权手术部位感染率较高(3.1% vs 1.5%),但数据过于稀疏,未进行比较Meta分析。

局限性

  • 对照组手术部位感染率数据过于稀疏,未能进行比较Meta分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The perioperative use of tranexamic acid (TXA) has become popular among plastic surgeons for a variety of surgical procedures. The aim of this study was to perform a systematic review and meta-analysis on the results reported in the literature regarding the effect of perioperative systemic TXA administration in breast surgery. METHODS: The PubMed, MEDLINE, Embase, CENTRAL, and CINAHL databases were searched for both randomized clinical trials and observational studies. Effect estimates were pooled across studies using random effects models and presented as weighted odds ratio with corresponding 95% confidence interval. RESULTS: A total of five studies encompassing 1139 patients undergoing mastectomy with or without immediate implant or free flap-based breast reconstruction or breast-conserving surgery with or without axillary lymph node dissection were included. Perioperative intravenous administration of TXA significantly reduced the risk for hematoma (7.3% versus 12.9%; OR, 0.43; 95% CI, 0.23 to 0.81) and seroma formation (11.5% versus 19.9%; OR, 0.57; 95% CI, 0.35 to 0.92) in comparison to the control group. In the studies measuring the postoperative drainage amount, the mean difference was 132 mL (95% CI, 220 to 44 mL). No thromboembolic event occurred in either group. The weighted surgical-site infection rate was higher in the control group (3.1% versus 1.5%). However, these data were too sparse to perform comparative meta-analysis. CONCLUSION: Evidence of this study suggests that perioperative administration of TXA significantly reduces the risk for postoperative hematoma and seroma formation in breast surgery, whereas the risk for thromboembolic events and postoperative infection is not increased.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Liechti R, van de Wall BJM, Hug U, et al. Tranexamic Acid Use in Breast Surgery: A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2022. PMID: 36729428. doi:10.1097/PRS.0000000000010071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。